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ABSTRACT
Heat shock proteins present a complex family of proteins exerting chaperone-like activities that are
classified according to their molecular weight. We especially explored protective functions of induc-
ible heat shock protein 70, the mitochondrial heat shock protein 60 and 10, and the small heat shock
proteins HSP27 and aB-crystallin against ischemic, reoxygenation-mediated injury using trans-
genic animals and hearts under in vivo conditions and in isolated cardiac myocyte-derived cells
using adenoviral vectors. We noted with great interest that differential protective effects are exerted
by specific hsps. For example, alpha-B-crystallin and constitutive hsp70 markedly protect micro-
tubular structure in cardiac myocytes from ischemia-induced injury. Inducible hsp70, hsp60 and
hspl0 when coexpressed, and hsp27 and aB-crystallin have an overall protective effect against
ischemic injury as determined by the release of enzymes like creatine kinase and LDH. We did not
note inflammatory or immune responses elicited by the expression ofhsps in transgenic animals and
cardiac myocytes. The specific cell types in which hsps are expressed may contribute to the pro-
tective effect of hsps versus their inflammatory and immunogenic effects when expressed in other
cell types. Infect. Dis. Obstet. Gynecol. 7:55-57, 1999. (C) 1999 Wiley-Liss, Inc.
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eat shock proteins (hsps) form a diverse group
of proteins that are classified according to
their molecular weight. Most members of the hsp
family exert a chaperone or chaperonin-like func-
tion inside the cell, allowing proteins in the
crowded intercellular environment to reach their
proper final folding state in an accelerated fashion
and avoiding folding structures that are not produc-
tive and lead to protein denaturation. This chaper-
one function results in a protective effect of hsps
against noxious insults like heat ischemia and ex-
posure to toxic chemicals. Several investigators
have indicated that hsps can also exert an inflam-
matory role and serve as antigenic targets for the
immune system and, in this way, can be detrimen-
tal in certain pathophysiological circumstances. In
this paper, the beneficial and protective features of
hsps will be highlighted. The hsps discussed in
further detail are the inducible hspT0, the small
hsps hsp27 in humans or hsp25 in rodents, and
alpha-B-crystallin. In addition, the mitochondrial
hsps hsp60 and hspl0 that form the chaperonin
complex in mitochondria are also considered.
A description of the response of the inducible
hspT0 to ischemia follows. We noted some time ago
that ischemia of the dog heart leads to a marked
increase in the messenger RNA and protein level
for the inducible hspT0, e’3 These findings raised
the question whether increased expression of
hspT0 could lead to a protective effect against isch-
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emic injury. We initially investigated this question
by stably transfecting H9C2 cells, leading to an
H9C2-cell line which overcxpresscd the human in-
ducible hsp70. We found a significant increase in
resistance to an ischemic stress in the H9C2 cells
overexpressing the inducible hsp70.4
In subsequent studies, we wanted to determine
if this protective effect could also be induced under
in vivo conditions. We therefore generated trans-
genic mice in which the rat inducible hspT0 is
driven by a human cytomegalovirus enhancer
chicken actin promoter,s In initial studies, we used
an isolated perfused mouse heart model to inves-
tigate protective effects of increased expression of
hspT0 against ischemic injury. Hearts were har-
vested from transgene-positive mice and trans-
gene-negative litter mates and submitted to perfu-
sion and subsequently to sero flow ischemia for 20
minutes and reflow in the Langendorf perfusion
setup. Recovery of contractile function was deter-
mined, the release of creatine kinase was investi-
gated, and, in addition, myocardial infarct size was
quantitated by a tetrazolium stain that exhibits a
red color when exposed to viable myocardial tissue
and a pale colorless stain in ischemic myocardium.
We found that in hearts obtained from transgenic
mice, the infarct zone was decreased by 40%.s In
addition, contractile function at 30 minutes of re-
flow was doubled, and the efflux of creatine kinase
was decreased by 50%. These findings, therefore,
clearly indicate that protection against ischemic in-
jury occurred in this isolated perfused heart model.
In subsequent studies performed in collabora-
tion with Dr. Wolfe at the University of California
San Francisco, we determined infarct size in a
mouse in vivo model.6 The left coronary artery was
occluded for 30 minutes, followed by 120 minutes
of reperfusion. Infarcts were set in anesthetized
mice overexpressing the inducible hspT0 transgene
and in control mice. Infarct size was then deter-
mined after sacrifice of the animals by staining with
tetrazolium, and we found that the infarct size was
decreased by 50% in hspT0-positive transgenic
mice. Expression of the hspT0 transgene in a large
number of cardiac myocytes in cell culture can also
be achieved by using adenoviral vectors. The
hspT0 transgene was cloned into the E1 region of
the viral vector, and infection of myocytes resulted
in a significant increase in inducible hspT0 levels in
marked protective effects against simulated isch-
emia.7
In subsequent studies brief episodes of myocar-
dial ischemia were used, leading to so-called myo-
cardial stunning. Myocardial stunning occurs under
conditions in which brief periods of ischemia do
not to lead to permanent myocyte necrosis but re-
sult in a significant decrease in myocardial function
after the ischemia is relieved.8 For this purpose, we
developed an in vivo mouse model in which re-
gional epicardial strains could be measured as an
indicator of ischemia-induced myocardial malfunc-
tion. In addition, isolated perfused hearts were
used to determine the contractile recovery after 10
minutes of global ischemia. In both of these mod-
els, the in vivo mouse model and the isolated heart,
we found that expression of hsp70 protected
against postischemic myocardial dysfunction in-
duced by brief ischemic episodes or myocardial
stunning.
Related to the protective effect of hsp60 and
hspl0, we performed studies in collaboration with
Dr. Mestril. For these studies, the hsp60 and hspl0
were cloned either by themselves or in combina-
tion into a human adenovirus five vector. Isolated
neonatal myocytes were infected with the virus and
then submitted to simulated ischemia. We ob-
tained the very interesting result that only the co-
expression of hsp60 and hspl0 could mediate a
protective effect against simulated ischemia. In
contrast, if hsp60 by itself or hspl0 by itself were
expressed, no protective function could be elicited.
The last set of results relate to the protective
effect of small hsps, hsp27 and alpha-B-crystallin.
The small hsps arose most likely from a primordial
gene and have a similar structure containing three
exons.9 These small hsps form large multimcric
units, and proteins that are not in their final folding
stage bind to the outside of this large oligomeric
complex. To determine if increased expression of
the small hsps could result in a protective effect,
we cloned alpha-B-crystallin and, separately, hsp27
into an adenoviral vector. The cardiac myocytc
submitted to simulated ischemia that were infected
with the adenoviruses expressing specific hsps
were then subsequently examined for resultant
damage. We observed that both hsp27 and alpha-
B-crystallin led to a significant protective effect
measured by release of creatine kinase or LDH in
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isolated myocytes submitted to simulated isch-
emia.1 To investigate the detailed mechanism of
protection, we investigated the integrity of specific
skeletal structures in cardiac myocytes infected
with different hsps and submitted to simulated
ischemia. Especially when microtubular integrity
was determined by indirect immunofluorescence
using confocal microscopy and image analysis, we
noted a significantly better protection of microtu-
bular integrity in myocytcs overexpressing alpha-
B-crystallin. In contrast, when hsp27 was overex-
pressed, no protection of microtubular structure oc-
curred. We also noted that the constitutive hsp70
provided for increased microtubular integrity, in
contrast to the inducible hspT0, which had no pro-
tective effect on microtubular structures. 11
Related to the general protective effect of
hsp27, we noted with great interest that the phos-
phorylation status of hsp27 does not play a signifi-
cant role for this function. For example, when the
three phosphorylatible serines 15, 78, and 82 were
mutated to alanine, the same protective effect was
mediated by the phosphorylation mutant versus
the wild type hsp27.
In summary members of the hsp family, the in-
ducible hsp70, constitutive hsp70, hsp60 and
hspl0, and the small hsps hsp27 and alpha-B-
crystallin have very significant protective effects
against ischcmic injury under in vivo conditions
and in isolated cardiac myocytes. The detailed tar-
get for the protective effect is different for the dif-
ferent hsps. For example, related to cytoskeletal
structures, the integrity of microtubules is well pre-
served by alpha-B-crystallin but not by hsp27. In
addition, the inducible hsp70 protects microtubule
structure but not constitutive hsp27. It will there-
fore be of great interest to determine the detailed
mechanism by which specific hsps exert their pro-
tective function. It will also be of interest to deter-
mine whether increased expression of hsps in
transgenic animals is tolerated without evidence of
an inflammatory or immune response. In the trans-
gcnic animals we used, no such effect was ob-
served; however, we have targeted hsps largely to
cardiac myocytes that are not a competent im-
mune-presenting cell, and, in this way, we may not
have noted a down-side of increased hsp expres-
sion.
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